ALERE INC (ALR) Downgraded by Zacks to UNDERPERFORM

Zacks Investment Research downgraded shares of ALERE INC (ALR) from NEUTRAL to UNDERPERFORM on October 03, 2012, with a target price of $18.40.

Alere Inc., formerly known as Inverness Medical Innovations, Inc., provides products and services, which focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Alere is headquartered in Waltham, Massachusetts.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

To get a free copy of the research report on ALERE INC (ALR),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .